Pharmacokinetics, oral bioavailability and metabolism of a novel isoquinolinone-based melatonin receptor agonist in rats

The Structure and Functions of P-Glycoprotein

(2010) Y. Li et al.   CURRENT MEDICINAL CHEMISTRY

Recent advances in the development of melatonin MT1and MT2receptor agonists

(2010) Marco Mor et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

3-Methoxylphenylpropyl amides as novel receptor subtype-selective melatoninergic ligands: characterization of physicochemical and pharmacokinetic properties

(2010) Jing Zhu et al.   XENOBIOTICA

Melatonin Treatment for Insomnia in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder

(2009) Lisa M Bendz et al.   ANNALS OF PHARMACOTHERAPY

N-(Anilinoethyl)amides: Design and Synthesis of Metabolically Stable, Selective Melatonin Receptor Ligands

(2009) Silvia Rivara et al.   ChemMedChem

Molecular Mechanisms of Melatonin Anticancer Effects

(2009) Steven M. Hill et al.   INTEGRATIVE CANCER THERAPIES

Development of an optimized procedure for the preparation of rat intestinal microsomes: comparison of hepatic and intestinal microsomal cytochrome P450 enzyme activities in two rat strains

(2009) A. Bruyère et al.   XENOBIOTICA

Agomelatine Treatment of Major Depressive Disorder

(2008) Christian R Dolder et al.   ANNALS OF PHARMACOTHERAPY

Metabolism of melatonin by cytochrome P450s in rat liver mitochondria and microsomes

(2008) Igor Semak et al.   JOURNAL OF PINEAL RESEARCH

Jet lag: Therapeutic use of melatonin and possible application of melatonin analogs

(2008) Venkataramanujan Srinivasan et al.   Travel Medicine and Infectious Disease